Experts Decry “Unsustainable” Drug Prices

by Admin | April 9, 2015 3:53 pm

April 9, 2015—The coming “tsunami” of high-priced specialty drugs for cancer and other chronic conditions threatens to undermine the U.S. healthcare system’s financial integrity, a panel representing physicians, patients, and payers warned at a Capitol Hill briefing[1] today organized by the Campaign for Sustainable Rx Pricing.  


You must be registered to read complete articles (it's quick, easy, and 100% free). Click here to register[2].    Already registered? Click here to login[3]. (340B Health members, Drug Discount Monitor subscribers, and 340B Coalition conference attendees: Use your existing username and password.)

 

Endnotes:
  1. a Capitol Hill briefing: http://www.csrxp.org/congressional-briefing-resources/
  2. Click here to register: https://secure.340bhealth.org/340Binformed/Subscribe.aspx
  3. Click here to login: http://340binformed.org/reader-login/

Source URL: https://340binformed.org/2015/04/experts-decry-unsustainable-drug-prices/